Adhesion Barrier: Introduction
A medical implant that is used for decreasing unusual scarring is called Adhesion Barrier. It is used to reduce abnormal internal scarring following surgery by separating the internal tissues and organs during healing.
These barriers are most commonly used for surgical procedures in the department of orthopaedic, cardiovascular, gynaecology, reconstructive and urological surgeries.
The Global Adhesion Barrier Market Forecast:
The adhesion barriers market is expected to grow at 6.9% CAGR over the forecast period 2021 to 2028. It will be worth USD 590.55 million in 2020 and USD 1068.48 million by 2028. This growth is due to an increase in the number of sports injuries and the increasing volume of surgeries.
Market drivers include the growing geriatric population and the increase in surgical procedures. This is due to the increasing number of invasive procedures that pose a high risk for complications after surgery. Global Adhesion Barrier Market Report provides an in-depth analysis of the market. The report includes a comprehensive analysis on key segments, market drivers, trends, restraints, competitive environment, and other factors that play a significant role in the market.
The Global Adhesion Barrier Market Overview:
The growth is expected to be driven by improvements in healthcare infrastructure and the increased availability of trauma centres. The market is also being driven by an increase in sports-related injuries.
Stanford Children’s Health estimates that there are 30 million children who play some type of sport, with more than 10% suffering injuries. There were 51.4 million orthopaedic procedures performed in the U.S. in 2015, confirmed by the Centers for Disease Control and Prevention (CDC). The demand for advanced adhesion barrier products will rise with the increasing number of orthopaedic procedures.
Market growth has also been fueled by an increase in neurological disorders, gynaecological disorders, ophthalmic disorders, and cardiac disorders. According to the British Heart Association, there are 7.4 million people with heart and circulatory diseases. In 2019, approximately 27% of all deaths in Britain were due to heart and circulatory disease. These disorders require surgical intervention at specific times. This increases the need for adhesion barriers.
The market is also growing due to rising healthcare spending and FDA approvals for adhesion barriers. Health Canada approved the SurgiWrap film adhesion barriers from Keir Surgical in March 2018 for sale in Canada.
Market growth is expected to be boosted by favourable reimbursement policies and increasing awareness of various surgical procedures.
For More Details: https://crediblemarkets.com/sample-request/adhesion-barrier-market-805749
The Global Adhesion Barrier Key Market Trends:
The market share for general/abdominal surgery is expected to be significant.
Postoperative patients are at risk from the adhesive disease. Many gynaecologists and obstetricians perform a variety of surgical procedures that can result in pelvic adhesions. These complications include infertility, small bowel obstruction, chronic pelvic pain, difficulty in treatment and complexity during future procedures. Adhesion barriers have been shown to reduce adhesion-related complications during abdominal surgery. Adhesion barriers are cost-effective for preventing adhesion-related complications in open surgery.
Market growth will also be boosted by expansions of companies and the development of abdominal barriers. For example, Baxter, for USD 350 million, acquired Seprafilm Adhesion Barrier from Sanofi in February 2020. Seprafilm is used to treat adhesions during abdominal and pelvic surgery. The market for general/abdominal surgery is expected to grow at a significant rate during the forecast period.
The Key Market Segmentation of the Global Adhesion Barrier Market:
Global Adhesion Barrier Market can be divided into Product Types, Formulation, Applications, and Geographical landscapes, etc.
Global Adhesion Barrier Market Segmentation By Product Type:
Synthetic Adhesion Barriers
Hyaluronic Acid
Regenerated Cellulose
Polyethene Glycol
Others
Natural Adhesion Barriers
Collagen
Fibrin
Global Adhesion Barrier Market Segmentation By Applications:
General/Abdominal Surgeries
Gynaecological Surgeries
Cardiovascular Surgeries
Orthopaedic Surgeries
Neurological Surgeries
Others
Global Adhesion Barrier Market Segmentation By Formulation:
Film Formulations
Liquid Formulations
Gel Formulations
Global Adhesion Barrier Market Segmentation By Geographical Landscape:
North America
Europe
Asia Pacific
South America
The Middle East and Africa
Major Key Players in the Global Adhesion Barrier Market Are:
Sanof
R. Bard
Johnson & Johnson
Baxter International
Integra LifeSciences Holdings Corporation
Innocoll Holdings
FzioMed
Atrium Medical Corporation
MAST Biosurgery
Anika Therapeutics
The Covid-19 Impact Analysis:
Due to the COVID-19 pandemic, revenues from medical products, such as adhesion bars will be slightly lower in 2020 and 2021. The current pandemic has seen a decrease in surgical procedures. They are expected to increase in the fourth quarter of 2020. This is likely to impact the market growth. Our research shows that the market for adhesion barriers is likely to grow at an average CAGR of (1.4) – (0.4%)% over the next two years.
Buy Global Adhesion Barrier Market Report: https://crediblemarkets.com/reports/purchase/adhesion-barrier-market-805749?utf8=%E2%9C%93&license_type=single_user
The Global Adhesion Barrier Market Report Highlights:
Anika Therapeutics, Inc. announced that it had entered into acquisition agreements with Parcus Medical, an established, privately-held firm in sports medicine, and Arthrosurface, which is a major developer of the joint surface and preservation solutions to active patients.
Sanofi and Regeneron Pharmaceutics, Inc announced in December 2019 that they intend to streamline their collaboration for antibodies for Kevzara or Praluent and turn it into a royalty-based agreement.
Baxter International purchased Sanofi’s Seprafilm Adhesion barrier and all associated variables on February 20, 2020. Baxter’s advanced surgical services include hemostasis and tissue sealing as well as tissue restoration.
R.Bard was purchased by B.D. in December 2017. This allowed the companies to pool their resources and position themselves as global leaders in medical device technology.
Ethicon launched a SURGICAL powder-absorbable hemostat in January 2018 to prevent disruptive bleeding. This is a powdered, adjunctive hemostat that surgeons can use to manage disruptive bleeding more effectively. More than 60% of open surgery procedures are affected by disruptive bleeding, which can lead to rising healthcare costs and high mortality rates.
